These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 2504896

  • 41. To induce or not to induce: do patients at greatest risk for fatal rejection benefit from cytolytic induction therapy?
    Higgins R, Kirklin JK, Brown RN, Rayburn BK, Wagoner L, Oren R, Miller L, Flattery M, Bourge RC, Cardiac Transplant Research Database (CTRD).
    J Heart Lung Transplant; 2005 Apr; 24(4):392-400. PubMed ID: 15797738
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Monoclonal versus polyclonal antibody therapy for prophylaxis against rejection after heart transplantation.
    Kormos RL, Herlan DB, Armitage JM, Stein K, Kaufman C, Zeevi A, Duquesnoy R, Hardesty RL, Griffith BP.
    J Heart Transplant; 1990 Apr; 9(1):1-9, discussion 9-10. PubMed ID: 2107288
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Independent predictors of renal dysfunction after heart transplantation in patients with normal pretransplant renal function.
    Garrido IP, Crespo-Leiro MG, Paniagua MJ, Muñiz J, Vázquez-Rey E, Pérez-Fernández R, García-Lara J, Cuenca-Castillo JJ, Castro-Beiras A.
    J Heart Lung Transplant; 2005 Sep; 24(9):1226-30. PubMed ID: 16143237
    [Abstract] [Full Text] [Related]

  • 46. Comparison of immunosuppression therapy following heart transplantation: pretransfusion/azathioprine/ATG/prednisone versus cyclosporine/prednisone.
    Barnhart GR, Goldman MH, Hastillo A, Szentpetery S, Wolfgang T, Thompson J, Mohanakumar T, Katz MR, Rider S, Hanrahan J.
    J Heart Transplant; 1985 Sep; 4(4):381-4. PubMed ID: 3916511
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. The effect of immunosuppression on posttransplant lymphoproliferative disease in pediatric liver transplant patients.
    Younes BS, McDiarmid SV, Martin MG, Vargas JH, Goss JA, Busuttil RW, Ament ME.
    Transplantation; 2000 Jul 15; 70(1):94-9. PubMed ID: 10919581
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Cytomegalovirus infections in heart transplant recipients: relationship to immunosuppression.
    Costanzo-Nordin MR, Swinnen LJ, Fisher SG, O'Sullivan EJ, Pifarre R, Heroux AL, Mullen GM, Johnson MR.
    J Heart Lung Transplant; 1992 Jul 15; 11(5):837-46. PubMed ID: 1329959
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Renal transplantation with cyclosporine in the elderly population.
    Velez RL, Brinker KR, Vergne-Marini PJ, Nesser DA, Long DL, Trevino G, Dickerman RM, Helfrich GB.
    Transplant Proc; 1991 Apr 15; 23(2):1749-52. PubMed ID: 1905073
    [No Abstract] [Full Text] [Related]

  • 54. Renal transplantation at the Washington Hospital Center: experience with OKT3 and Minnesota antilymphoblast globulin for induction of immunosuppression.
    Jonsson J, Light JA, Korb SM.
    Clin Transpl; 1990 Apr 15; ():275-88. PubMed ID: 2129409
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Recipient selection algorithm for immunosuppression in cardiac transplantation: OKT3 vs triple therapy alone.
    Rabinov M, Benson E, Cochrane A, Williams T, Bergin P, Federman J, Esmore D.
    Transplant Proc; 1992 Feb 15; 24(1):167-8. PubMed ID: 1539226
    [No Abstract] [Full Text] [Related]

  • 57. OKT3 delays rejection crises after heart transplantation.
    Weimar W, Essed CE, Balk AH, Simoons ML, Hendriks GF, Wenting GJ, Mochtar B, Bos E.
    Transplant Proc; 1989 Feb 15; 21(1 Pt 3):2497-8. PubMed ID: 2495641
    [No Abstract] [Full Text] [Related]

  • 58. Meningism in a ten-month-old infant during OKT3 therapy.
    Rizzo JD, Rowe SA.
    J Heart Transplant; 1990 Feb 15; 9(6):727-8. PubMed ID: 2126036
    [Abstract] [Full Text] [Related]

  • 59. Randomized prospective trial of OKT3 for early prophylaxis of rejection after liver transplantation.
    Millis JM, McDiarmid SV, Hiatt JR, Brems JJ, Colonna JO, Klein AS, Ashizawa T, Hart J, Lewin K, Goldstein LI.
    Transplantation; 1989 Jan 15; 47(1):82-8. PubMed ID: 2521409
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.